No headlines found.
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
PRNewswire (Thu, 28-Mar 4:30 PM ET)
NHS invests in the high yield debt securities markets. At least 80% of the Fund will be invested in below investment grade (high yield) debt securities (including corporate loans) of US and foreign issuers. The Fund may invest up to 20% of its managed assets in other securities. The Fund will attempt to maintain an average (dollar-weighted) portfolio quality of B/B to Ba/BB, with less than 20% of the Fund’s portfolio composed of securities rated Caa/CCC or lower. The fund can utilize leverage through the issuance of preferred stock, privately placed notes and privately placed perpetual preferred shares.
Neuberger Berman High Yield Strategies trades on the AMEX stock market under the symbol NHS.
As of April 23, 2024, NHS stock price declined to $7.99 with 67,840 million shares trading.
NHS has a beta of 0.57, meaning it tends to be less sensitive to market movements. NHS has a correlation of 0.18 to the broad based SPY ETF.
NHS has a market cap of $207.17 million. This is considered a Small Cap stock.
In the last 3 years, NHS stock traded as high as $13.57 and as low as $6.95.
NHS has underperformed the market in the last year with a return of +1.2%, while the SPY ETF gained +24.2%. In the last 3 month period, NHS fell short of the market, returning +4.4%, while SPY returned +4.8%. However, in the most recent 2 weeks NHS has outperformed the stock market by returning -0.2%, while SPY returned -2.6%.
NHS support price is $7.96 and resistance is $8.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NHS stock will trade within this expected range on the day.